Status:
NOT_YET_RECRUITING
Effects of a Brown Seaweed Tart Cherry Blend in Mild-moderate Hypertension
Lead Sponsor:
University of Central Lancashire
Conditions:
Hypertension
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The brown seaweed species Ascophyllum nodosum is rich in bioactive polysaccharides, proteins, peptides, lipids, pigments, and polyphenols. Similarly, Montmorency tart cherry (Prunus cerasus L.) is hig...
Detailed Description
Hypertension is the leading preventable risk factor for cardiovascular disease and mortality, causing over 75,000 annual UK deaths. It affects 31% of males and 26% of females, with about 30% having un...
Eligibility Criteria
Inclusion
- Aged from 18-65 years
- Systolic blood pressure 120 to 139 mmHg
- Not taking prescribed medicine for blood pressure management
- Ability to complete written questionnaires independently
- Able to provide informed consent
Exclusion
- Diagnosed with diabetes mellitus and/ or coronary heart disease
- Pregnant and lactating women
- Allergy to peppermint
- Habitual consumption of peppermint products
- Regular consumption of antioxidant supplements
- Body mass index larger than 40.0 kg/m2
- Current enrolment in other clinical trials of other external therapies
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06559982
Start Date
May 1 2025
End Date
July 1 2026
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Lancashire
Preston, Lancashire, United Kingdom, PR4 0PE